| Primary |
| Obsessive-compulsive Disorder |
26.8% |
| Bipolar Disorder |
14.3% |
| Attention Deficit/hyperactivity Disorder |
12.5% |
| Depression |
10.7% |
| Generalised Anxiety Disorder |
8.9% |
| Myoclonic Epilepsy |
8.9% |
| Product Used For Unknown Indication |
5.4% |
| Social Phobia |
3.6% |
| Anxiety |
1.8% |
| Insomnia |
1.8% |
| Maternal Exposure Timing Unspecified |
1.8% |
| Off Label Use |
1.8% |
| Small Cell Lung Cancer |
1.8% |
|
| Completed Suicide |
8.7% |
| Disinhibition |
8.7% |
| Oculogyric Crisis |
8.7% |
| Drug Interaction |
4.3% |
| Drug Intolerance |
4.3% |
| Electrocardiogram Abnormal |
4.3% |
| Hepatitis C |
4.3% |
| Incoherent |
4.3% |
| Neutrophil Count Increased |
4.3% |
| Off Label Use |
4.3% |
| Rhabdomyolysis |
4.3% |
| Serotonin Syndrome |
4.3% |
| Somatic Delusion |
4.3% |
| Speech Disorder |
4.3% |
| Suicidal Ideation |
4.3% |
| Thermal Burn |
4.3% |
| Toxicity To Various Agents |
4.3% |
| Unresponsive To Stimuli |
4.3% |
| Urinary Retention |
4.3% |
| Urinary Tract Infection |
4.3% |
|
| Secondary |
| Product Used For Unknown Indication |
40.1% |
| Obsessive-compulsive Disorder |
16.4% |
| Depression |
11.4% |
| Attention Deficit/hyperactivity Disorder |
6.8% |
| Anxiety |
4.0% |
| Bipolar Disorder |
3.7% |
| Drug Exposure During Pregnancy |
1.9% |
| Schizophrenia |
1.9% |
| Depressive Symptom |
1.5% |
| Generalised Anxiety Disorder |
1.5% |
| Small Cell Lung Cancer |
1.5% |
| Blood Cholesterol Increased |
1.2% |
| Hypertension |
1.2% |
| Impulse-control Disorder |
1.2% |
| Mental Disorder |
1.2% |
| Enuresis |
0.9% |
| Insomnia |
0.9% |
| Suicide Attempt |
0.9% |
| Toxicity To Various Agents |
0.9% |
| Diabetes Mellitus |
0.6% |
|
| Toxicity To Various Agents |
17.9% |
| Respiratory Arrest |
10.4% |
| Obsessive-compulsive Disorder |
9.0% |
| Completed Suicide |
7.5% |
| Weight Decreased |
7.5% |
| Interstitial Lung Disease |
6.0% |
| Speech Disorder |
6.0% |
| Death |
4.5% |
| Vomiting |
4.5% |
| Euphoric Mood |
3.0% |
| Hepatitis |
3.0% |
| Hypervigilance |
3.0% |
| Serotonin Syndrome |
3.0% |
| Suicidal Ideation |
3.0% |
| Syncope |
3.0% |
| Unresponsive To Stimuli |
3.0% |
| Asthenia |
1.5% |
| Cystic Lymphangioma |
1.5% |
| Drug Eruption |
1.5% |
| Drug Interaction |
1.5% |
|
| Concomitant |
| Product Used For Unknown Indication |
21.3% |
| Depression |
9.9% |
| Anxiety |
8.1% |
| Drug Use For Unknown Indication |
7.5% |
| Obsessive-compulsive Disorder |
7.5% |
| Schizophrenia |
6.3% |
| Bipolar Disorder |
5.7% |
| Hypertension |
4.5% |
| Diabetes Mellitus |
3.0% |
| Prophylaxis |
3.0% |
| Type 2 Diabetes Mellitus |
3.0% |
| Anxiety Disorder |
2.7% |
| Ill-defined Disorder |
2.7% |
| Multiple Myeloma |
2.7% |
| Rheumatoid Arthritis |
2.7% |
| Psychotic Disorder |
2.4% |
| Hypothyroidism |
2.1% |
| Blood Cholesterol Increased |
1.8% |
| Mania |
1.8% |
| Ankylosing Spondylitis |
1.5% |
|
| Vomiting |
9.1% |
| Paranoia |
7.3% |
| Somnolence |
7.3% |
| Depression |
5.5% |
| Diabetes Mellitus |
5.5% |
| Rash |
5.5% |
| Renal Failure Acute |
5.5% |
| Renal Impairment |
5.5% |
| Suicidal Ideation |
5.5% |
| Tinnitus |
5.5% |
| Tremor |
5.5% |
| Affect Lability |
3.6% |
| Anxiety |
3.6% |
| Drug Ineffective |
3.6% |
| Drug Screen False Positive |
3.6% |
| Metabolic Syndrome |
3.6% |
| Musculoskeletal Stiffness |
3.6% |
| Overdose |
3.6% |
| Respiratory Arrest |
3.6% |
| Road Traffic Accident |
3.6% |
|
| Interacting |
| Bipolar Disorder |
42.9% |
| Schizophrenia |
14.3% |
| Suicide Attempt |
14.3% |
| Anaesthesia |
7.1% |
| Anorexia Nervosa |
7.1% |
| Anxiety |
7.1% |
| Depression |
7.1% |
|
| Suicidal Ideation |
30.0% |
| Toxicity To Various Agents |
20.0% |
| Dyskinesia |
10.0% |
| Multiple Drug Overdose Intentional |
10.0% |
| Tremor |
10.0% |
| White Blood Cell Count Increased |
10.0% |
| Withdrawal Syndrome |
10.0% |
|
